Oppenheimer & CO Inc Sangamo Therapeutics, Inc Transaction History

Oppenheimer & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $126,391 - $189,144	-29,600 Reduced 38.64%	47,000 $230,000
Q2 2022 Aug 08, 2022	SELL	$3.28 - $6.21 $137,268 - $259,888	-41,850 Reduced 35.33%	76,600 $317,000
Q4 2021 Feb 02, 2022	SELL	$7.29 - $10.97 $268,636 - $404,244	-36,850 Reduced 23.73%	118,450 $888,000
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $374,482 - $499,171	-41,563 Reduced 21.11%	155,300 $1.4 Million
Q2 2021 Aug 03, 2021	BUY	$10.17 - $12.64 $1.33 Million - $1.65 Million	130,300 Added 195.75%	196,863 $2.36 Million
Q1 2021 May 10, 2021	BUY	$10.88 - $17.05 $724,205 - $1.13 Million	66,563 New	66,563 $834,000

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.